The $30 Million Bet: CNS Investors Are Back — and Registrational Trial Design Hasn’t Kept Up
Serina Therapeutics just closed a $30 million private placement at a 68% premium to fund a registrational trial for...
Endpoint Selection
Serina Therapeutics just closed a $30 million private placement at a 68% premium to fund a registrational trial for...